JW to collaborate with Samsung Medical Center

Published: 2012-11-30 06:56:00

Updated: 2012-11-30 06:56:00

JW Pharmaceutical said Tuesday it has signed a memorandum of understanding (MOU) with Samsung Medical Center (SMC) for the research collaboration of new refractory cancer treatments.

According to the Agreement, JW Pharmaceutical will discover new cancer candidates while SMA will be responsible...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK